Laxatives

Case-based learning: constipation in adults

It is important that pharmacists understand how to appropriately and safely manage patients with constipation in light of new Medicines and Healthcare products Regulatory Agency guidance announced in August 2020.…

Supported content

Medicines regulator introduces age restrictions on OTC laxatives following safety review

Over-the-counter laxatives for adolescents aged 12 to 17 years can now only be supplied under the supervision of a pharmacist, following the results of a review by the Medicines and Healthcare products Regulatory Agency.…

Medicines regulator to publish review into safety of OTC laxatives

The Medicines and Healthcare products Regulatory Agency is to publish the results of a four-year review into the safety of over-the-counter stimulant laxatives, a spokesperson has confirmed.…

Potential interaction between diuretics and laxatives found

Researchers have identified a plausible drug–drug interaction between laxatives and non-potassium-sparing diuretics.…

Constipation treatment could lengthen cancer survival

Study findings support a role for the mu opioid receptor in cancer progression.…

Laxatives may slow worsening rigidity in Parkinson’s disease

Researchers found flexor muscle stiffness plateaued in Parkinson’s patients taking all types of laxatives.…

Linaclotide, lubiprostone and prucalopride interactions

How to avoid potential pharmacokinetic and pharmacodynamic interactions with the latest medicines for managing constipation.…

Constipation: managing the condition in adults

How to assess patients with constipation and select the right treatment to minimise the risk of complications.…

Regulator rejects call for stricter control of laxative sales

A call by an eating disorder charity for tougher controls on the sale of laxatives has been rejected by the Medicines and Healthcare products Regulatory Agency.…